Ludwig-Maximilians-Universität München, D-80336 Munich, Germany
![]() |
ABSTRACT |
---|
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Embryonic
epithelial membrane transporters are organized into transporter
families that are functional in several epithelial organs, namely, in
kidney, lung, pancreas, intestine, and salivary gland. Family members
(subtypes) are developmentally expressed in plasma membranes in
temporospatial patterns that are 1) similar for one subtype
within different organs, like aquaporin-1 (AQP1) in lung and kidney;
2) different between subtypes within the same organ, like
the amiloride-sensitive epithelial sodium channel (ENaC) in lung; and
3) apparently matched among members of different transporter
families, as -ENaC with AQP1 and -4 in lung and with AQP2 in kidney.
Finally, comparison of temporal expression patterns in early embryonic
development of transporters from different families [e.g., cystic
fibrosis transmembrane conductance regulator (CFTR), ENaC, and outer
medullary potassium channel] suggests regulatory activating or
inactivating interactions in defined morphogenic periods. This review
focuses on embryonic patterns, at the mRNA and immunoprotein level, of
the following transporter entities expressed in epithelial cell plasma
membranes: ENaC; the chloride transporters CFTR, ClC-2,
bumetanide-sensitive Na-K-Cl cotransporter, Cl/OH, and
Cl/HCO3; the sodium glucose transporter-glucose transporter; the sodium/hydrogen exchanger; the sodium-phosphate cotransporter; the ATPases; and AQP. The purpose of this article is
to relate temporal and spatial expression patterns in embryonic and in
early postnatal epithelia to developmental changes in organ structure
and function.
embryonic epithelia; membrane transporter; ion channel; morphogenesis
![]() |
INTRODUCTION |
---|
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
PHYSIOLOGICAL
ANALYSIS OF embryonic epithelial membrane transporters is
providing increasing data on gene messages and their specific proteins
in defined embryonic cell populations. Although recent studies on the
expression of membrane transporters in differentiated organs have been
summarized in outstanding reviews (e.g., 26, 30, 37, 79), work of the
past decade on transporters in embryonic epithelial organs and their
cell types has not yet been reviewed critically. In particular, a
comparative description of membrane transporter expression, in terms of
temporal and spatial patterns, of the same transporter or transporter
family in different embryonic epithelial organs has not been made.
Organogenesis of epithelial systems, in general, is governed by basic
processes that are similar in different epithelial organs, such as lung
(38), kidney (40), pancreas (34,
69), and salivary gland. Among these processes are early
induction of mesenchymal blastema and its transition to epithelium,
branching morphogenesis of induced epithelial primordia, and actions of
signal molecules, as illustrated for some of these events in renal
organogenesis (Fig. 1). Because
stages of morphogenesis are well defined, and morphogenic
factors and mechanisms are being evaluated increasingly for different
epithelial organs (e.g., 38, 40), the present article attempts to
relate changes in membrane transporter expression to developmental
stages. Although progress in the area of epithelial transport
differentiation would appear to have been substantial since the
publication of an early
review1 on renal transport,
most of the key processes such as the role of established transcription
factors (e.g., Pax-2, WT-1,
HNF-1a, SP1, and SP3) in the temporospatial
expression of embryonic membrane transporter patterns remain to be
understood.
|
![]() |
AMILORIDE-SENSITIVE EPITHELIAL SODIUM CHANNEL |
---|
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
The highly selective amiloride-sensitive epithelial sodium channel (ENaC) mediates electrogenic sodium transport and is the rate-limiting step of sodium absorption in epithelia of the distal nephron and colon, airways, and salivary ducts. Although renal, colonic, and salivary ENaC-mediated sodium absorption maintains extracellular sodium homeostasis, pulmonary sodium transport is the primary driving force for lung liquid clearance at birth. Inherited ENaC mutations are inactivating (loss of function), as in pseudohypoaldosteronism type I (PHA-1), or activating (gain of function), as in Liddle's syndrome. Targeted disruption of subunit loci in the embryo has uncovered much of their functional roles in ENaC-mediated sodium transport.
Expression of ENaC subunits (12) has been measured specifically in embryonic and perinatal epithelia of lung (1, 24, 48, 61, 67, 71, 72, 74, 75, 87, 88, 98, 99, 101) and kidney (44, 62, 49, 97, 100) in humans (61, 98, 99), guinea pigs (24), rats (44 67, 71, 74, 75, 87, 97, 99), and mice (1, 48, 49, 62, 72, 87).
In embryonic rat lung (Fig. 2), -ENaC
expression begins (67, 88) in the late canalicular and
saccular stage [embryonic days (E)17/18-E19],
concomitant with Na-ATPase (66), but not in the earlier
pseudoglandular stage; it rises to the highest mRNA subunit abundance
around term, with a simultaneous increase (75) of
aquaporin-4 (AQP4; see Fig. 4), and it decreases from postnatal days
(P)1-P7 (88). The
-
(87) and
-subunit expressions, by contrast, are induced
postnatally (P1-P7). Similar to this divergent temporal
pattern is the effect of exogenous corticosteroids (88).
Dexamethasone, given to mothers between E17 and
E19, increased embryonic
-subunit expression but not that
of the
- and
-subunits within 8 h after injection, much like
the effect of the glucocorticoid and thyroid-stimulating hormone
together (67), whereas thyroid hormone triiodothyronine
(T3) alone, or combined with dexamethasone, did not increase any of the
subunits (88). Because the
-ENaC subunit alone suffices
to express part of the sodium channel activity (12), the
sole rise of this subunit either in early postnatal or in embryonic
lung, depending on the species (24, 61, 87), should be
capable of driving initial alveolar fluid clearance. Indeed, the first
report (48) on the
-null phenotype [
-ENaC (
/
)]
indicated that lungs of these newborn mice, although histologically normal, showed patchy filling of the alveolar space, and the animals died within 40 h after the transition to air-breathing. By
contrast, the
-ENaC deletion (62), although associated
with a lethal phenotype, did not result in the development of
respiratory functional or morphological failure, suggesting that
-
and
-subunits alone might generate sodium channel activity just
appropriate for perinatal respiratory survival.
|
The sensitivity of pulmonary ENaC expression to oxygen content of the
medium had been established earlier in cultured fetal rat lung
epithelia (71), where, remarkably, the switch from 3 to
21% O2 increased the abundance of -,
-, and
-ENaC
subunits, implying that a similar rise on P1
(75) might be induced by the change in blood
O2 content after birth. Although the fetal expression
change in response to O2 (from 3 to 21%) was homogeneous in all subunits (71), the unstimulated pattern
(87) showed early embryonic temporal patterns that were
differential for the subunits. The expression of the
-subunit
follows the
-ENaC pattern, but that of
-ENaC rises gradually from
P1 to adult (87). The embryonic spatial
patterns are similar for
- and
-subunits, with a prevalence of
the
-subunit in early embryonic acinar and in small airway cells,
whereas the
-subunit localized mostly to small airway cells.
Remarkably,
- and
-subunits in the adult appear to localize to
the AII cell type (87). The O2-induced ENaC
subunit mRNA levels (71, 74) imply the induction of
O2-responsive elements (71) and, indeed, a
change in intracellular superoxide expression was associated with the
activation of a redox-sensitive transcription factor, nuclear
factor-
B (74), which was blocked, as was the
O2-induced increase in ENaC, by a superoxide scavenger.
Subunit temporal expression patterns were further examined (88,
101) in lung and colon and found to be differential both within
the lung and particularly between these organs. Lung -abundance is
consistently higher than that of
- (88) or
-
(101), most impressively so from E19 to
P2 and from P9 to P28 (Fig. 2).
Remarkably, the mRNA amount of each subunit on P1 is almost
as high as on P28. Thus the early expression specifically of
the
-ENaC subunit (Fig. 2), even before the need for ENaC protein
function, is to ensure neonatal fluid removal (clearance), in concert
with the early expression of AQP (see Fig. 5) from epithelial surfaces. Nevertheless, pulmonary differences in temporal expression of mRNA
abundance (Fig. 2) suggest divergent and independent functions of the
subunits that might also imply differential subunit O2 sensitivities.
In human lung, ENaC mRNA appeared to rise continuously from fetal to
adult expression level (99), but -ENaC message was found only at the end of the second trimester (61),
whereas all subunits were first expressed in week 21 (98). The low and differential expressions of the subunits
in week 24 cultured lung (98) were increased by
a factor of two to three by dexamethasone, not by thyroid (T3) hormone
(88, 98), mainly at the transcriptional level. These
effects on ENaC mRNA abundances suggest that promoter regions of ENaC
subunits might have glucocorticoid response element sequences, but they
do not imply any functional (posttranslational) consequences.
Renal ENaC expression patterns (Fig. 2), by contrast, although established early in nephrogenesis mostly by principal cells (44), are increasingly responsible for postnatal sodium homeostasis; it is relevant in this context that the temporospatial pattern of nephron differentiation from deep to superficial cortex (40) puts the renal workload at birth, in several species, on the almost mature nephron generations in the deep cortex. In humans, however, nephrogenesis is completed at about weeks 34-35 of gestation. Total renal embryonic rat ENaC subunit mRNA abundance is very low but increasing from E16 to E19 (97), and it rises abruptly from E19 to E22 to almost adult levels of expression at P1-3 in all subunits (Fig. 2), indicating that the distal nephron does not have the divergent embryonic subunit mRNA expression pattern that characterizes pulmonary ENaC development.
A detailed study of -ENaC in the ureteric bud (UB) revealed that,
surprisingly, this subunit and the sodium channel protein are expressed
and functional (44) in rat UB (and embryonic collecting tubule) well before filtrate delivery, suggesting that the other subunits (100) also might be functional in this progenitor
cell of the cortical collecting duct (CCD) cell populations. Moreover, the acquisition of apicobasal cell polarity, a hallmark of
nephrogenesis (39) after mesenchyme-to-epithelium
transition (45), also pertains to the sided expression of
the ENaC functional protein (41, 44). The early expression
(E17) was confirmed because each of the subunit antisense
riboprobes hybridized to collecting ducts, whereas only
- and
-subunits were detected in the most distal uroepithelia
(100). Although whole kidney
-ENac mRNA abundance
increased, and
- and
-subunit abundance decreased after birth,
there was a striking shift of the collecting duct expression pattern
from inner medullary to cortical localization (100).
The functional roles of the ENaC subunits in epithelial sodium
transport were studied in several mouse organ systems and
subunit-knockout models (1, 48, 49, 72). As mentioned for
the -ENaC (
/
) phenotype, failure of pulmonary fluid clearance
was the primary cause of early postnatal death although
-ENaC
transcripts could not be detected in both lung and kidney
(48). In subsequent work, the
-ENaC (
/
) with
transgenic expression of
-ENaC resulted in a partial restoration of
-mediated sodium reabsorption specifically in lung, and liquid
clearance was sufficient for the newborn to survive the early postnatal
period; however, renal manifestations of reduced
-ENaC expression
were salt wasting and metabolic acidosis with elevated aldosterone,
thus resembling a compensated PHA-1 syndrome. When the
-subunit gene
was disrupted (72), the mutant newborn mice (
-ENaC
m/m) still were able to clear their lung liquid despite a
sixfold reduction in ENaC-mediated tracheal transport, but compensated
metabolic acidosis and elevated aldosterone levels indicated a
compensated PHA-1 phenotype on a normal-salt diet. On low-salt intake,
however, the reduced
-ENaC mutants revealed the PHA-1 phenotype with
renal and colonic expression, such as elevated serum potassium (6 mM),
lower blood pressure, and elevated aldosterone (72).
Of interest,
-ENaC (
/
) mice, which are hyponatremic and
hyperkalemic with corresponding urinary excretion patterns and elevated
aldosterone, display the collecting duct dysfunction phenotype of human
PHA-1 without defects in pulmonary or renal morphology
(62). Last, the
-ENaC (
/
) resulted in a lethal
PHA-1 phenotype (1), which, however, did not lead to
respiratory failure during the first 24 h postnatally but to severe hyperkalemia of probably renal origin that appeared to be the
leading cause of death in the
-mutants (1). Colonic ENaC expression patterns were qualitatively similar for all subunits, the increase in their mRNA abundance being gradual, with
-subunit mRNA having the highest value throughout (101).
In conclusion, expression patterns of ENaC subunits in kidney, lung (Fig. 2), and colon differ fundamentally, and regulatory mechanisms, e.g., O2 and steroid hormones, appear to act in organ-specific ways in embryonic and postnatal differentiation.
![]() |
INWARDLY RECTIFYING K+ CHANNELS |
---|
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Inwardly rectifying K+ (Kir) channels constitute diverse subfamilies, such as ATP-sensitive and ATP-dependent potassium channels, and they participate, among many diverse functions, in maintaining potassium homeostasis and resting conductance. For the Kir family, as for ENaC, distinct temporal expression patterns have been described, specifically for some Kir members in embryonic (Braun GS, Huber SM, Veh RW, Segerer S, and Horster MF, unpublished observations) and in postnatal (Braun GS, Huber SM, Veh RW, Segerer S, and Horster MF, unpublished observations; 77, 111) renal epithelial development. Thus ROMK, Kir6.1, and its associated sulfonylurea receptor SUR2, were found to be expressed in a development-dependent mode (Braun GS, Huber SM, Veh RW, Segerer S, and Horster MF, unpublished observations) in defined stages of collecting duct morphogenesis, in mesenchyme-to-epithelium transition, and in nephron formation, where they might serve specific developmental functions. It is of particular interest that Kir6.1 (protein) is faintly expressed in mesenchymal blastema, upregulated at the mRNA and protein level in condensed mesenchyme, and downregulated in the S-shaped body (47). In collecting duct ontogeny, Kir6.1 and SUR2 mRNAs are downregulated with time, whereas ROMK2 mRNA is upregulated by cAMP, suggesting that vasopressin might function as transcriptional regulator in development (Braun GS, Huber SM, Veh RW, Segerer S, and Horster MF, unpublished observations). The ROMK isoforms, when analyzed by immunofluorescence, are selectively expressed in the apical plasma membrane of mature thick ascending limb of Henle and of CCD principal cells (30, 37). By contrast, ROMK is not expressed in the nephrogenic zone or in midcortical CCD of postnatal week 1 rat kidney, whereas midcortical CCDs (week 3) were clearly stained (111). This postnatal change in ROMK protein abundance may be responsible for the increase in the number of open potassium channels, i.e., the number of functional channel proteins reported earlier in postnatal rabbit principal cells (77).
It may be concluded that embryonic ROMK, Kir6.1, and SUR2 expressions are involved in developmental processes such as cell cycle, mitosis, and mesenchyme conversion rather than in potassium homeostasis and that these latter functions are gradually acquired for the mature nephron (30).
![]() |
CHLORIDE TRANSPORTERS |
---|
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Chloride (anion) transporters (channels) not only have a leading role in cell volume regulation, but they also participate in stabilizing potassium-mediated membrane potential and in acidifying intracellular compartments. Chloride transporter genes from distinct families that are developmentally expressed include the cystic fibrosis transmembrane conductance regulator (CFTR) (22, 34, 41, 59, 60, 63, 86, 90, 91, 110), ClC-2 (42, 43, 65), ICln (42, 102), the bumetanide-sensitive Na-K-Cl symporter (NKCC2) (51, 78, 89, 96), the Cl/HCO3 antiporter (58), and the Cl/OH antiporter (80).
CFTR
The cAMP-activated chloride channel, a member of the ABC transporter superfamily, functions as a regulator of other channels and may be more important in regulating embryonic channel expressions, cationic and anionic, than has been appreciated thus far. Expression of the CFTR has been measured in embryonic and postnatal lung (34, 59, 60, 63, 86, 90, 91), kidney (22, 41), and pancreas (34, 90) in humans (22, 34, 59, 60, 90, 91), rabbits (63), and rats (41, 86). Although up- or downregulation of some transporters coincides with the transition from embryonic to postnatal life (Fig. 2 and see Fig. 4), CFTR and ClC-2 apparently have a more complex expression pattern. In human lung, CFTR mRNA is found in the first trimester, and mRNA and protein in the second, i.e., very early in gestation (59). In cystic fibrosis lung, CFTR expression (34) but no cAMP-stimulated fluid secretion was reported for explants (59). Despite this secretory conductive defect, lung morphology was normal, suggesting additional embryonic mechanisms of chloride and fluid secretion compensating for the defective CFTR secretory pathway, as postulated also for the CFTR-deficient mouse, which has normal embryonic lung morphogenesis (110). The supposed CFTR-independent chloride transport is upregulated by keratinocyte growth factor, which, probably due to osmotic fluid accumulation, causes cystic dilation and disrupted branching morphogenesis of lung buds (110). Analysis of the human embryonic temporospatial pattern of CFTR by in situ hybridization (60, 91) revealed a bronchial centrifugal expression gradient (60), diminishing from bronchi to bronchioles and to prealveolar tubes, specifically in AII cells and their precursors, whereas the mesenchyme did not express the channel message. When CFTR mRNA signals were evaluated throughout development (91), from human embryonic week 10 to postnatal year 2, a more differentiated pattern emerged, namely, high expression levels in all distal epithelia and small airways in the first trimester, relatively reduced proximal expression in second, and high expression in small distal airways, but reduced in the future alveolar space, in the third trimester; neonatal lung had no alveolar or tracheal expression (91). Expression levels of CFTR mRNA, in general, are lower in respiratory epithelia at all embryonic stages compared with those of the gastrointestinal tract, where expression of CFTR was specific to progenitor cells of intestinal crypts (90), in particular on apical surfaces (65). The polar membrane distribution of CFTR (63), as for other membrane channel types and transporters (40), is acquired with cell differentiation; specifically, the protein in E22 (rabbit) is distributed in a nonpolar way, and it becomes localized exclusively to the apical membrane on E29 (63). Like other embryonic transporters (106), CFTR functional activity, without correspondingly large changes in CFTR mRNA, is modulated in embryonic lung (rat) by steroid hormones (86), suggesting translational or posttranscriptional regulation of CFTR in embryonic distal lung epithelia. Similarly, CFTR functional activity decreased progressively during late- gestation morphogenesis, from the pseudoglandular to the saccular stage (86), but CFTR mRNA abundance remained unchanged.In embryonic kidney (Fig. 3), by
contrast, CFTR mRNA abundance in UB cells declined between gestational
E15 and postnatal P1, rising transiently by a
factor of 10 between P1 and P7
(41), a period corresponding to the late stage of rat
kidney branching morphogenesis (40), and was downregulated
thereafter.
|
Of interest in this context is the finding (41) that wild-type and truncated forms of CFTR mRNA have different patterns of developmental regulation in UB. The human renal CFTR expression pattern (22) is characterized by early appearance (weeks 12-19) of the multifunctional (79) CFTR protein in the apical plasma membrane of UB, but not in comma- or S-shaped body, a pattern similar to that in pancreas (34) and lung during branching morphogenesis.
To summarize, the early expression of CFTR, its transient decrease in the last gestational (rat) trimester (Fig. 3), its bronchial centrifugal expression gradient, and the shift from apolar to apical localization might suggest CFTR regulatory functional roles not only for other chloride channels (e.g., ClC-2, ICln) but also for ENaC, which is upregulated concomitantly (44).
ClC-2
This member of the large ClC family is expressed ubiquitously, and embryonic renal and pulmonary mRNA temporal expression patterns are quite similar. Renal ClC-2 mRNA is most abundant in E19 (rat), and it is downregulated in kidney, lung, and intestine perinatally (65), suggesting developmental housekeeping functions that become less important in postnatal life. Embryonic ClC-2 expression is highest in kidney and least in lung, indicating that lung fluid secretion is driven by many chloride conductances, which are either cAMP dependent or independent. Although ClC-2 and CFTR are coexpressed in embryonic intestine, along apical surfaces of villi and crypts (65), their spatiotemporal expression patterns in embryonic lung and kidney are different (41, 42, 65), in contrast to the patterns for ClC-2, which are similar in both arborizing organs (42). Because early pulmonary bronchi and renal CCD have branching morphogenesis in common, the temporal pattern of ClC-2 mRNA expression was analyzed in UB and collecting duct epithelia (42). In embryonic UB cells (Fig. 3), mRNA encoding the ubiquitous volume-regulatory ClC-2 is highly abundant, and it is downregulated in the postnatal collecting duct (42). This pattern corresponds to that in lung, where embryonic chloride and fluid secretion into the lumina appear to have morphogenetic functions. In fact, the renal embryonic precursor cell type of the CCD principal cell, the UB cell at the tip of the branching ureter, expresses embryonic ClC-2 mRNA at the single-cell level (43). The lumen of the ampullary part of the UB may thus be maintained by ClC-2-mediated chloride and by AQP2-mediated fluid secretion.In lung, ClC-2 mRNA is expressed in an almost identical temporal
pattern, and downregulation of ClC-2 apparently is associated with the
switch of embryonic respiratory epithelia from fluid secretion to
reabsorption at birth, when -ENaC (88) and AQP1 (94, 107) are upregulated.
To conclude, the changing functional role (79) of the CFTR mRNA pattern in nephrogenesis, as mentioned, might be that of a molecular switch downregulating ClC-2-mediated chloride (and fluid) secretion and upregulating ENaC-mediated sodium (and fluid) absorption on initiation of glomerular filtration. The inversely related mRNA abundances of these transporters in different embryonic and perinatal stages appear to support this hypothesis.
Expression of ICln (Fig. 3), a further swelling-activated, volume-regulatory channel or channel regulator (102), was compared with that of ClC-2 during renal branching morphogenesis (42). Although ClC-2 mRNA abundance increased from E15 to E17, peaked around P3, and decreased from P3 to P7 (Fig. 3), similar to the temporal pattern in lung (65), mRNA expression of ICln increased during the entire embryonic and postnatal period of development (42), extending data in mouse kidney where a single transcript was found to be expressed at similar levels in embryonic stages between E7 and E17 (102). The pattern of ICln mRNA abundance, to summarize, follows that of increasing vectorial solute transport after P7 with its, by now, enhanced requirement for volume regulation (47), whereas the ClC-2 temporal expression pattern suggests specific embryonic functions in epithelia undergoing branching morphogenesis.
Embryonic epithelial cell volume regulation and its developmental course have been evaluated in UB cells and CCD cells in culture, and it was shown that the mature type of hypotonic swelling-activated chloride conductance may evolve already between E17 and P1 (47). Embryonic UB cells had a high and constitutively active chloride conductance, whereas perinatal and postnatal cells, by contrast, expressed a chloride conductance that was activated by hypotonic cell swelling (47), and the embryonic conductance type was downregulated simultaneously.
The chloride transporter NKCC2 is highly and early (E16.5, mouse) expressed in the metanephric kidney (51), and three isoforms have been identified in embryonic human kidney (96), where loss-of-function mutations can cause the antenatal (inherited) hypokalemic alkalosis of Bartter's syndrome (85). The first embryonic expression (E14.5, mouse) is localized to the distal limb of the immature loop of Henle, in cells close to future glomeruli, before the morphological differentiation of the loop into thin and thick ascending segments (51). These data were confirmed and extended to the postnatal nephrogenic (P3/P4, rat) zone and to deeper cortical areas (78). NKCC2, as in embryonic mouse, is first expressed in macula densa cells of the thick ascending limb, and it appears earlier than the sodium-phosphate cotransporter (NaPi) in the pars recta (78). These and other transporters are expressed embryologically even before completion of organ structure (e.g., of the post-S-shaped stages in the nephrogenic zone) and the onset of filtration or of ventilation, such as in embryonic (sheep) lung epithelia in culture, where NKCC2 may drive the chloride secretory pathway (89), suggesting that these molecules might have a morphoregulatory role. This function is by now also ascribed to polycystin, an integral membrane protein and polycystic kidney disease 1 (PKD-1) gene product, in human (29, 50) and in mouse (28, 31, 95) embryonic kidney, lung, salivary gland, and pancreas, where polycystin is highly expressed throughout major stages of organogenesis, such as mesenchymal condensation and tissue patterning. In the kidney, polycystin expression is very high in differentiating and very low in differentiated UB and CCD mouse epithelia, respectively (29). Transcript levels were detected in UB branches on E12 (31), peaked from E16 to E19, and were abruptly downregulated to very low adult levels in week 1/2. Indeed, the PKD-1 gene product polycystin was shown to regulate branching morphogenesis of mouse UB (95), and its mode of function may resemble that of a channel/receptor subunit. In human kidney, the PKD-1 protein is expressed in collecting duct and distal convoluted tubule on week 20 (50), and at a high level even earlier (week 14) in UB/CCD apical membrane but not in mesenchyme (29), with a general decrease after week 18 in kidney and pancreatic duct to undetectable levels in adult (29).
The chloride/anion antiporters, Cl/OH in proximal straight tubule (80) and Cl/HCO3 in mesonephric collecting tubule (58), have distinct developmental expression patterns. In mesonephric kidney, which in rabbit is functional from E13 to E19 (in sheep from E15 to E55, and in humans from week 5 to week 16), the collecting duct expresses (in ~1/3 of the CD cells) the intercalated A-type cell of the later metanephric kidney, as indicated by apical H-ATPase and basolateral Cl/HCO3 immunoexpression (58), suggesting that lineages of the metanephric collecting duct cell populations are already expressed in the mesonephros. In proximal straight tubule (rabbit), the functional activity of the Cl/OH antiporter was about sevenfold less in neonatal compared with adult S2 segments (80) and notably similar to the rate change in the Na/H antiporter (NHE3), indicating that developmental changes in proximal tubule NaCl transport are mediated by similar changes of these cooperating transporters (80). The heterogeneous families of chloride transporters, to summarize, appear to serve various undefined embryonic and postnatal functions, as suggested by the distinct temporal patterns of up- and downregulation in different morphogenic periods.
![]() |
SODIUM-GLUCOSE SYMPORTER-GLUCOSE UNIPORTER |
---|
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Transcellular vectorial movement of glucose in epithelial cells, i.e., uptake and release, results from concerted actions of members of two families of regulated glucose transporters, the isoforms of sodium-glucose symporter (SGLT) in the apical and of glucose uniporter (GLUT) in the lateral plasma membrane. Their embryonic expression is tissue specific and regulated developmentally.
SGLT and GLUT have been evaluated in embryonic and postnatal stages of intestine (9, 14, 20, 56, 57, 73, 82, 92), kidney (4, 108), lung (35, 84), and pancreas (36, 69) in humans (20, 56), pigs (73), cats (9), rabbits (4), and rats (14, 35, 36, 57, 69, 82, 84, 92, 108).
SGLT-1, the high-affinity symporter in human intestine, is expressed first in week 17 of gestation (20), and it increases from a low embryonic expression (57) with development. Apical glucose (SGLT-1) and D-fructose uptake (rat), when studied from P1 to P42 (92), had a steep rate increase after P21 to adult, and it declined thereafter. Interestingly, the ratio of intestinal glucose uptake to that for galactose and for fructose changes with postembryonic ontogeny (73). Although the galactose-to-glucose and fructose-to-glucose transport ratios have a similar course between birth and P10, galactose-to-glucose ratio decreases sharply after P10, and that of fructose to glucose, as might be anticipated, increases further (73). Monosaccharide transporters, in general, are already acquired embryonically before substrate delivery to these transporters (73), similar to ENaC expression in kidney and lung before the onset of filtration and ventilation, respectively.
SGLT-2-mediated glucose transport in late embryonic renal brush-border membranes has the same affinity but a reduced maximal velocity (Vmax) compared with that in adults, suggesting that the increase in SGLT-2 expression (4) may also represent an adaptive intestinal change of transporter availability in response to the gradual postnatal shift in diet (9). This latter factor appears to be relevant for the biphasic expression pattern of the ileal sodium-dependent bile acid (taurocholate) transporter ASBT mRNA (81). Both mRNA and protein abundance are high on E22, downregulated in P1-P7 relative to E22, and markedly increased at weaning (P21, rat). This pattern is similar to rBAT mRNA expression, a cystine-related absorption system in embryonic renal pars recta (25).
Expression patterns of organic ion transporters related to the organic cation transport family (OCT) were examined recently in murine development (69a). Although NKT/mOAT (55), Roct, OCT-1, and NLT transcript levels increase during embryonic development almost pari passu in proximal tubule, their mRNA expression in extrarenal sites decreases impressively, thus raising the possibility that OCTs might have a role in morphogenesis.
Renal SGLT-1 mRNA is expressed on E18 (rat), and it increases up to P1 (108). By contrast, SGLT-2 expression began on E17, rose up to E19, and declined between E19 and P1 when, notably, the size of the message changed from an embryonic (2.6-kb) to the postnatal (2.2-kb) form, suggesting developmental splice variants of the low-affinity symporter similar to the CFTR embryonic variant (41).
GLUT-5 in human small intestine is immunoexpressed as early as gestational week 15 in the apical membrane (56), whereas GLUT-2 mRNA has been detected already in week 11 (20). This differential temporal pattern of GLUT expression pertained to all isoforms; i.e., GLUT-5 in embryonic intestine was expressed at lower abundance than GLUT-2 and both increase from low embryonic expression with development (57), whereas GLUT-1 has an early and high embryonic expression (20) and decreases postnatally, as is true for pulmonary (35) GLUT-1. Immunoreactive localization in embryonic period E10-E20 confirmed that the GLUT-1 (high-affinity) transport protein is expressed earlier than -2 and -5, and it disappears in the newborn enterocyte, whereas the others are increasingly expressed. The progressive increase in GLUT-5 transcript level was correlated with the fructose uptake pattern (14, 73); i.e., GLUT-5 mRNA expression in P22 is upregulated by luminal fructose after completion of weaning, and dietary fructose levels induce GLUT-5 mRNA abundance specifically and instantaneously (82).
Pulmonary GLUT-1 mRNA, protein, and glucose uptake in embryonic AII cells (E20, rat) are upregulated during culture in glucose-free medium and decreased in high-glucose medium (84). Mechanisms regulating transcriptional rates in response to the transported substrate for GLUT-1 and -5 (82) are unknown. In embryonic lung, in addition, the estradiol-induced magnitude of change in GLUT-1 mRNA was similar to that of protein and of glucose uptake rate, suggesting a steroid-induced increase in membrane transporter density (35).
Pancreatic immunohistochemical GLUT-2 is absent in E20
-cells (36), and it is faintly expressed in
P1, suggesting that glucose-induced insulin secretion is
developmentally reduced at the transporter level. However, in
E11 pancreas, GLUT-2 protein is expressed in endoderm before
bud morphogenesis, but the protein- and insulin-positive cells in acini
and in duct epithelia are lost by E19, indicating embryonic
and postnatal lineages of insulin expression (69).
SGLT and GLUT, to conclude, apparently have distinct isoform expression patterns, which might be similar, however, in different organs for a given isoform, as in GLUT-1, and dependent on substrate load, as in GLUT-5.
![]() |
NHE |
---|
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
The renal proximal convoluted tubule (PCT) has a central role in acid-base homeostasis, and its major part of proton secretion is carried by NHE via the low intracellular sodium concentration established by the Na-K-ATPase. The NHE isoforms (1-4) are expressed developmentally.
Embryonic and early postnatal NHE expression has been evaluated by transport activity, by mRNA and protein abundance, or by immunolocalization, in kidney of sheep (33), rabbit (2, 5), rat (3, 6, 17, 109), and in rat jejunum (16, 17).
PCT embryonic apical membrane abundance of Na/H (NHE3) protein and of amiloride-insensitive sodium uptake into brush-border vesicles (E29-30, rabbit) is much lower compared with adult (5). Although Vmax of the embryonic transporter was about threefold lower than in the adult, suggesting an increase in the number of functional transporters or in the turnover number of individual transporters, the Michaelis-Menten coefficient value (Km) was similar throughout ontogeny. Previous work had reported transport rates, Vmax, Km, and amiloride sensitivity of NHE3 to be higher at P7 than at P21 or the adult stage (109), indicating an increased capacity for antiport at the early stage. As might be anticipated, maternal glucocorticoid application (5) induced Vmax of the embryonic NHE3 antiport activity to rise precociously to an adult level, which might have been due to an increase in transcriptional efficiency. NHE3, when immunolocalized on P1, was not detected in vesicle or in early S-shaped body of the nephrogenic zone, and it was first expressed in the apical plasma membrane of the fully formed S-shaped body (6), whereas medullary thin and thick loops of Henle expressed the adult staining pattern already at this P1 stage. NHE3 mRNA abundance (rabbit) increased from very low on E30 and P1, only slightly in week 1, and sharply in week 3 to an adult level (2). In subsequent stages (rat: weeks 2, 3, 6, and adult), the pH-dependent renal sodium uptake (17) was higher in weeks 2-6 than in adult, and the abundance of NHE1 and NHE4 mRNA decreased similarly. By contrast, intestinal uptake increased slightly from week 2 to week 6 but steeply from there to adult, whereas intestinal NHE1 message remained constant (17). NHE3 expression is probably regulated at several levels, because the relative contribution of NHE3 and NHE2 to total transport activity changed with ontogeny. In early stages (weeks 2 and 3), NHE2 and NHE3 carried 40 and 60% of transport activity, respectively, whereas later (week 6) the contribution of NHE3 had increased to some 90% (16). Intestinal NHE3 mRNA and protein abundance were increased by corticosteroids on P18 about twofold (16).
Besides corticosteroids (5), thyroid hormones regulate ontogenic transcriptional activities, and these were studied in P17-20 (rat) with respect to NHE3 antiporter activity, mRNA, and protein abundance (3). Hypothyroid renal cortical NHE3 mRNA abundance was similar to that of euthyroids, but transporter activity and apical membrane protein abundance were lower. In hyperthyroids, by contrast, mRNA, protein, and transporter activity were all higher than in euthyroids (3), suggesting a regulatory role for thyroid hormones in PCT functional differentiation.
The glucocorticoid-induced embryonic expression (sheep) of NHE3 activity in PCT is similar to that during natural embryonic-postnatal transition (33); i.e., Vmax increases and Km is constant, suggesting an increase in transporter numbers under the regulatory control of corticosteroids. Remarkably, total renal sodium reabsorption was unchanged, which emphasizes the differential effects of the glucocorticoid on transport expression. NHE1 and NHE4 mRNA abundance (rat) in cortical basolateral plasma membranes decreased with postnatal ontogeny from week 2 to adult, concomitant with pH-dependent sodium uptake into basolateral vesicles (17), whereas NHE1 mRNA abundance (rabbit) was expressed at adult level already on P1 and did not change further (2) and protein profiles of both NHE3 and NHE1 were similar to those of their mRNAs. Glucocorticoid treatment in week 1 (rabbit) increased NHE3 mRNA (~2-fold) and protein (~3-fold) abundance but not that of the high-NHE1 expression level (2). To summarize, it appears that not only the contributions of NHE isoforms to pH and sodium homeostasis change with embryonic and, specifically, postnatal ontogeny but also their response to steroid-induced expression.
![]() |
NAPI |
---|
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
A systematic evaluation of the intracortical developmental (rat: P1, P13, P22, adult) profile of NaPi expression, by immunolocalization and in situ hybridization, revealed that NaPi protein and mRNA are expressed, as expected, only in those PCT of inner cortex, specifically in juxtamedullary PCT, that had acquired a brush border (93). Surprisingly, however, NaPi-2 was not expressed in any of the nephrogenic structures, i.e., vesicle, comma- and S-shaped body, and it appeared rather homogeneously throughout the cortex only on P13, i.e., when nephrogenesis (rat) is almost completed (40). The adult pattern (week 6) was reached after abundance in superficial PCT appeared downregulated compared with juxtamedullary PCT (93). NaPi transport on P21 in renal brush-border membrane vesicles of hypothyroid rat (23) was specifically and acutely restored by T3, in both Km and Vmax, and T3 also increased the abundance of NaPi-2 mRNA to control values, independently of corticosteroid effects (23).
![]() |
ATPASES |
---|
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Na-K-ATPase is the key transporter in cellular solute and water homeostasis. With the increasing demand for transcellular solute and fluid movement in epithelia after the embryonic period of development, expression of transporters such as ENaC (88, 101), SGLT (57), and NHE (5) is upregulated and may contribute to the ubiquitous rise in the abundance of Na-K-ATPase.
Na-K-ATPase expression in embryonic lung (15, 19, 52, 66, 88) and kidney (10, 32, 70, 103) has been measured in mice (19), rats (52, 66, 103), guinea pigs (32), rabbits (15), sheep (70), and humans (10), whereas expressions of renal and gastric H-K-ATPase were studied postnatally in rabbit (18) and mouse (64), respectively.
Embryonic distal lung cells are to become air space epithelia, and
their high Na-K-ATPase activity serves sodium absorption and thus fluid
clearance after birth, whereas much of the ATPase abundance in
embryonic airway (bronchiolar) cells is part of the chloride-secretory
and thus fluid-secretory process that is required in early lung
morphogenesis. In lung, epithelial cell Na-K-ATPase undergoes two major
changes, i.e., in turnover rate and in the amount of enzyme in plasma
membranes (15). At term (E30-P1), a fourfold
increase in the ouabain-sensitive Rb uptake indicates a major change in
the antiporter turnover rate, whereas postnatal development is
characterized by a threefold increase of binding sites per cell, i.e.,
in the number of antiporters without an apparent change in the turnover
rate (15). The embryonic Na-K-ATPase 1- and
1-
subunit mRNAs (66) were found in cultured distal epithelia
to be faintly expressed on E17, increased on E20,
and declined on E20-21. Remarkably, however, the two
subunits appeared to be regulated differentially because the
E17 mRNA steady-state level was higher for the
1-subunit,
but the increase in late canalicular/early saccular stage
(E20) was higher for
1 than for
1 (66).
Also, the major rise in Na-K-ATPase mRNA was at the transition from
canalicular to saccular stage, whereas the enzyme activity increased at
the saccular stage.
Pulmonary embryonic mRNA abundance profiles of these two isoforms of
the enzyme increased coordinately from mouse E14.5 (where they are similar to adult values) to the highest levels (6- to 8-fold
higher than adult) at P1, representing the terminal saccular stage (19), and mRNA abundance of both isoforms decreased
from P3 to reach final adult values at P13. The
spatial pattern, by in situ hybridization, is characterized by intense
1-isoform signals in proximal bronchial epithelia on P1,
whereas
1 is expressed increasingly from E14.5 to
P1 in both proximal and distal epithelia (19).
It is of interest that maternal glucocorticoid treatment (52) changes the steady-state levels of the isoforms
differentially. When dexamethasone was applied specifically from
E14 to E16, both
1-subunit mRNA and protein
increased on P17, but mRNA and protein of the
1-subunit
remained unchanged (52).
Renal embryonic Na-K-ATPase activity rose in sheep (E132)
after cortisol (48 h) to levels of P1 activity; this change,
however, was much higher than that of mRNA and protein
(70), suggesting that most of this short-term effect was
posttranscriptional, i.e., not consequent to de novo synthesis of the
1-subunit, and thus similar to the effect in embryonic guinea pig
kidney (32) and rat lung (88). By contrast,
cortisol effects on the renal Na/H antiporter in embryonic sheep
(E132) appear to be preferentially transcriptional
(33). The unstimulated temporal pattern of Na-K-ATPase activity in rat juxtamedullary PCT shows an almost twofold increase from E21 to P1 (103) but much less
enzyme activity in the induced mesenchyme. Detailed analysis of PCT
enzyme activity (32) during embryonic-neonatal transition
(guinea pig) revealed an intricate pattern, i.e., a constant
Km and a large increase in
Vmax and
- (by a factor of 7) and
-subunit
(by a factor of 4) protein abundance but only a small increase (by
factor of 1.5-2) in subunit mRNA abundance, indicating either
posttranscriptional upregulation of Na-K-ATPase protein synthesis or
lower degradation (32).
In the metanephros of humans (10), as well as in those of
other species (39), the acquisition of basolateral
membrane sidedness of the enzyme is developmentally regulated because
both apical and basolateral localization of the -subunit is seen
throughout a major part of gestation, and final polarization may be
organized at the level of the
2-isoform expression involving the
sorting pathway of the Na-K-ATPase. This important conclusion is based on the fact that
2-subunit mRNA and protein, but not
1-subunit protein, are expressed apically in distal nephron and collecting duct
segments during early and midgestational metanephrogenesis. Postnatally,
2-subunit mRNA and protein are downregulated whereas the
1-subunit protein, by contrast, was upregulated
(10).
H-K-ATPase protein in CCD intercalated cells is expressed early
(weeks 1-2, rabbit) in apical plasma membrane
(18), and thus ensures, together with the V-ATPase
(18), acid excretion in the transitional period. Closer
examination of the (mouse) gastric H-K-ATPase expression by membrane
immunoassay revealed apparently similar control mechanisms for subunit
expression, i.e., very low levels for both the - and
-subunit
protein from P1 to P15, with a sharp rise to
adult level on P30, and the increase was mainly due to
increased subunit mRNA levels (64). It appears justified
to conclude that recent work has emphasized differential developmental
roles of the Na-K-ATPase
- and
-subunits at the mRNA and protein
level, in both the process of sided expression and the enzyme's
upregulation under the control of steroids.
![]() |
AQP |
---|
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
AQPs are a family of highly conserved transmembrane channel proteins generally responsible for rapid osmotic water movements, and some nine members of this transporter family have been cloned in mammals to date. Their distribution patterns are organ and cell type specific, and their pulmonary and renal temporal developmental patterns differ fundamentally.
Expression of the aquaporins AQP1-4 in renal epithelia (7, 11, 21, 27 , 68, 76, 83, 104, 105, 106) and of AQP1, 4, and 5 in lung epithelia (13, 53, 54, 75, 94, 107) is acquired with embryonic and/or perinatal development in humans (21), sheep (11, 104), rabbits (13), rats (7, 53, 54, 75, 76, 83, 94, 105-107), and mice (27).
Temporospatial patterns are expressed differentially for each of the
aquaporins in both kidney and lung (Fig.
4). In the kidney (rat), AQP1-4 are
hardly detectable on E16 by immunohistochemistry (105). AQP1 mRNA rises sharply to a near-adult level in
week 1 whereas AQP2 is expressed already on E18
and increases steadily up to week 4. This early AQP2
transcript appearance is accompanied by vasopressin receptor
V2R mRNA expression (in situ hybridization) already at
E16 in embryonic collecting duct (68). At the
protein level, the earliest expression (E18) of AQP2 is in
UB apical membrane, whereas basolateral AQP3 is barely detected at this
stage and highly expressed on P1 (105). Except
for this embryonic divergence, basolateral AQP3 and apical AQP2
patterns appear to be similar. It is relevant in the context of CCD
cell lineage expression that on P1 all of the cells were
AQP2 positive, whereas on P11 principal cells (by exclusive
AQP2 expression) and intercalated cells (by V-ATPase expression) were
clearly distinct (76). Incidentally, some CCD cells on
P11 expressed both AQP2 and V-ATPase in the apical plasma
membrane, suggesting developmental transitional states between these
cell types. AQP4 mRNA has a faint embryonic expression (Fig. 4), and it
is continuously expressed after birth in kidney and lung up to
P40 (75, 105).
|
Because epithelial nephrogenesis (39) in many species, including rat, extends from embryonic into early postnatal life (P1-14), expression patterns of several epithelial membrane transporters also change during this later developmental phase (40). The increasing expression of AQP2 at the mRNA and protein level between P10 and P40 is paralleled by a similar rise in urine osmolality (27, 106). AQP2 mRNA abundance rose almost twofold from P10 to P20 (Fig. 4), and its protein in the principal cell apical plasma membrane stained faintly from P2 to P6, but strongly from P6 to P40 (106).
Remarkably, an adequate challenge to the signal cascade (e.g., dehydration or arginine vasopressin) when applied in the early (P1) postnatal phase (7) increases both AQP2 expression and, to a higher extent, protein insertion from the intracellular pool into the apical membrane of CCD, specifically of the glycosylated form, whereas urine osmolality remained at the nonactivated level. These latter data imply that factors in addition to AQP2 availability, V2R mRNA expression (68), and cAMP-mediated signal system capacity, as measured by developmental responses of osmotic water permeability in inner medullary collecting duct (83), contribute to the ontogeny of countercurrent function. AQP2, at any rate, is not a major limiting factor of early postnatal urinary osmotic concentration. Of particular interest, the pattern of glycosylation of the AQP2 protein switched from a preferentially nonglycosylated early form to the expression of both glycosylated and nonglycosylated forms of AQP2 in week 2 (7). When its expression was induced by glucocorticoid on P10 (106), AQP2 mRNA abundance rose by a factor of two and protein stain by a factor of eight, but there was no effect on AQP2 in adult kidney.
In human kidney, AQP1 and AQP2 are expressed as early as gestational week 12, when they appear, as shown by antibody localization, in the apical membrane of PCT and of UB, respectively (21). The pattern of glycosylation from embryonic to postnatal changed in AQP1, similar to that in rat AQP2 (7), such that the nonglycosylated protein was present throughout ontogeny, but the glycosylated subunits of AQP1 were detected only after birth, and AQP-1 in mature PCT and descending thin limb has been localized to the apical and basolateral membrane (21). AQP2, by contrast, is expressed only in UB-derived structures, beginning at gestational week 12 (21). Remarkably, V-ATPase was not detected at any embryonic stage in UB-derived cells (21), which further characterizes the collecting duct progenitor cell as a principal cell-like type (43, 46).
AQP1 mRNA is not expressed in mesonephros (E15-60, sheep); it appears in the metanephric PCT at a low level on E40 (11), and transcript abundance rises some sevenfold in the last trimester of gestation to reach adult levels in week 6 (104). AQP1 mRNA expression, similar to AQP2 in rat (106), increased by 43% on midgestational E74 (but not earlier) after glucocorticoid administration (104).
Lung water channel transcript expression, when analyzed systematically
from E19 to P21 in rat (94), reveals
distinct patterns for AQP1, 4, and 5 (Fig. 4) whereas AQP3 is not
expressed in distal lung (54). AQP1 transcript expression,
more than that of AQP4, increased simultaneously with osmotic water
permeability immediately after birth in rabbit (13). In
embryonic rat lung, by contrast, AQP1 protein is the first to appear
(54), probably similar to in sheep lung bud
(11), and its level rises severalfold from E20
to P1 (53) or to P5
(94), concomitant with the transition from secretion to
absorption of lung liquid (53). AQP1 transcript expression
had a sharp rise to its maximal transcript value at P2
(94) or P1 (107), and it rose
severalfold after maternal treatment with glucocorticoid not only
embryonically but also in P1 and even in adult lung
(53). The AQP1 ontogenic expression pattern in embryonic
lung, and the AQP2 pattern in kidney, appear to parallel those of ENaC
(Fig. 5); however, AQP1 is not expressed in epithelia of large airways and of alveoli. AQP4 mRNA has an expression pattern similar to AQP1 (107), beginning on
E20 with a sharp rise by a factor of eight to
P1/3 (75), and it declines from
there by a factor of two during week 1 to almost the adult level (75). This unstimulated pattern of AQP4 is lung
specific, and the protein localizes to postnatal basolateral membranes
of all airway cells but not to alveolar membranes. It is very relevant functionally that AQP4 responds to a change in O2 from 3 to
21% (75) in a manner similar to the change in ENaC
expression, and maximal coexpression of ENaC subunits and AQP4 occurs
on P1 (75). AQP4 mRNA increases by some 50%
after -adrenergic agonists and glucocorticoids (107).
The AQP5 transcript, by contrast, has a slow and steady increase from
E20 to P5 (94, 107), its maximum expression is after week 1, and there is no change after
glucocorticoid treatment (54).
|
In sum, developmental physiology of AQPs has been proven to be far more intricate than anticipated from work in other transporter families, because fluid transport functions most likely involve multiple AQPs acting in concert to maintain the delicate fluid balance not only on respiratory and secretory surfaces but also within the intracellular space during developmental transitional states.
![]() |
PERSPECTIVES |
---|
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Embryonic temporospatial expression patterns of some plasma membrane transporters have been described comparatively between epithelial organs, and they have been related to morphogenetic stages and evolving organ function. The mere description of embryonic expression patterns at the mRNA and immunoprotein level, however, can only provide a basis on which to evaluate causal relations in morphogenesis, cell polarization, and differentiation. Among the presently most interesting approaches to uncover causal links between regulatory entities are those that measure transporter and transcription factor patterns in defined transitional states (47) and interfere with those gene expressions in lung and kidney (e.g., 48, 62), the major embryonic transporter organs. However, we do not wish to leave the impression that this sole approach will enable us to draw a coherent picture of how embryonic epithelial membrane transporter expression is regulated.
![]() |
ACKNOWLEDGEMENTS |
---|
Sophia Horster is gratefully acknowledged for graphics work.
![]() |
FOOTNOTES |
---|
Research in the author's laboratory is financially supported by the Deutsche Forschungsgemeinschaft. This article was written during the grant period Ho 485/16-1/16-2.
Address for reprint requests and other correspondence: M. F. Horster, Universität München, Pettenkoferstr. 12, D-80336 Munich, Germany (E-mail: horster.med{at}qmx.de).
1 Horster, M. Principles of nephron differentiation. Am J Physiol Renal Fluid Electrolyte Physiol 235: F387-F394, 1978.
The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
![]() |
REFERENCES |
---|
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
1.
Barker, PM,
Nguyen MS,
Gatzy JT,
Grubb B,
Norman H,
Hummler E,
Rossier B,
Boucher RC,
and
Koller B.
Role of gamma ENaC subunit in lung liquid clearance and electrolyte balance in newborn mice. Insights into perinatal adaptation and pseudohypoaldosteronism.
J Clin Invest
102:
1634-1640,
1998
2.
Baum, M,
Biemesderfer D,
Gentry D,
and
Aronson PS.
Ontogeny of rabbit renal cortical NHE3 and NHE1: effect of glucocorticoids.
Am J Physiol Renal Fluid Electrolyte Physiol
268:
F815-F820,
1995
3.
Baum, M,
Dwarakanath V,
Alpern RJ,
and
Moe OW.
Effects of thyroid hormone on the neonatal renal cortical Na+/H+ antiporter.
Kidney Int
53:
1254-1258,
1998[ISI][Medline].
4.
Beck, JC,
Lipkowitz MS,
and
Abramson RG.
Characterization of the fetal glucose transporter in rabbit kidney. Comparison with the adult brush border electrogenic Na+-glucose transporter.
J Clin Invest
82:
379-387,
1988[ISI][Medline].
5.
Beck, JC,
Lipkowitz MS,
and
Abramson RG.
Ontogeny of Na/H antiporter activity in rabbit renal brush border membrane vesicles.
J Clin Invest
87:
2067-2076,
1991[ISI][Medline].
6.
Biemesderfer, D,
Rutherford PA,
Nagy T,
Pizzonia JH,
Abu-Alfa AK,
and
Aronson PS.
Monoclonal antibodies for high-resolution localization of NHE3 in adult and neonatal rat kidney.
Am J Physiol Renal Physiol
273:
F289-F299,
1997
7.
Bonilla-Felix, M,
and
Jiang W.
Aquaporin-2 in the immature rat: expression, regulation, and trafficking.
J Am Soc Nephrol
8:
1502-1509,
1997[Abstract].
9.
Buddington, RK,
and
Diamond J.
Ontogenetic development of nutrient transporters in cat intestine.
Am J Physiol Gastrointest Liver Physiol
263:
G605-G616,
1992
10.
Burrow, CR,
Devuyst O,
Li X,
Gatti L,
and
Wilson PD.
Expression of the 2-subunit and apical localization of Na+-K+-ATPase in metanephric kidney.
Am J Physiol Renal Physiol
277:
F391-F403,
1999
11.
Butkus, A,
Alcorn D,
Earnest L,
Moritz K,
Giles M,
and
Wintour EM.
Expression of aquaporin-1 (AQP1) in the adult and developing sheep kidney.
Biol Cell
89:
313-320,
1997[Medline].
12.
Canessa, C,
Schild I,
Buell G,
Thorens B,
Gautschi I,
Horisberger JD,
and
Rossier BC.
Amiloride-sensitive epithelial sodium channel is made of three homologous subunits.
Nature
367:
463-467,
1994[ISI][Medline].
13.
Carter, EP,
Umenishi F,
Matthay MA,
and
Verkman AS.
Developmental changes in water permeability across the alveolar barrier in perinatal rabbit lung.
J Clin Invest
100:
1071-1078,
1997
14.
Castello, A,
Guma A,
Sevilla L,
Furriols M,
Testar X,
Palacin M,
and
Zorzano A.
Regulation of GLUT5 gene expression in rat intestinal mucosa: regional distribution, circadian rhythm, perinatal development and effect of diabetes.
Biochem J
309:
271-277,
1995[ISI][Medline].
15.
Chapman, DL,
Widdicombe JH,
and
Bland RD.
Developmental differences in rabbit lung epithelial cell Na+-K+-ATPase.
Am J Physiol Lung Cell Mol Physiol
259:
L481-L487,
1990
16.
Collins, JF,
Xu H,
Kiela PR,
Zeng J,
and
Ghishan FK.
Functional and molecular characterization of NHE3 expression during ontogeny in rat jejunal epithelium.
Am J Physiol Cell Physiol
273:
C1937-C1946,
1997
17.
Collins, JF,
Xu H,
Kiela PR,
Zeng J,
and
Ghishan FK.
Ontogeny of basolateral membrane sodium-hydrogen exchange (NHE) activity and mRNA expression of NHE-1 and NHE-4 in rat kidney and jejunum.
Biochim Biophys Acta
1369:
247-258,
1998[ISI][Medline].
18.
Constantinescu, A,
Silver RB,
and
Satlin LM.
H-K-ATPase activity in PNA-binding intercalated cells of newborn rabbit cortical collecting duct.
Am J Physiol Renal Physiol
272:
F167-F177,
1997
19.
Crump, RG,
Askew GR,
Wert SE,
Lingrel JB,
and
Joiner CH.
In situ localization of sodium-potassium ATPase mRNA in developing mouse lung epithelium.
Am J Physiol Lung Cell Mol Physiol
269:
L299-L308,
1995
20.
Davidson, NO,
Hausman AM,
Ifkovits CA,
Buse JB,
Gould GW,
Burant CF,
and
Bell GI.
Human intestinal glucose transporter expression and localization of GLUT-5.
Am J Physiol Cell Physiol
262:
C795-C800,
1992
21.
Devuyst, O,
Burrow CR,
Smith BL,
Agre P,
Knepper MA,
and
Wilson PD.
Expression of aquaporins-1 and -2 during nephrogenesis and in autosomal dominant polycystic kidney disease.
Am J Physiol Renal Fluid Electrolyte Physiol
271:
F169-F183,
1996
22.
Devuyst, O,
Burrow CR,
Schwiebert EM,
Guggino WB,
and
Wilson PD.
Developmental regulation of CFTR expression during human nephrogenesis.
Am J Physiol Renal Fluid Electrolyte Physiol
271:
F723-F735,
1996
23.
Euzet, S,
Lelievre-Pegorier M,
and
Merlet-Benichou C.
Effect of 3,5,3'-tri-iodothyronine on maturation of rat renal phosphate transport: kinetic characteristics and phosphate transporter messenger ribonucleic acid and protein abundance.
Endocrinology
137:
3522-3530,
1996[Abstract].
24.
Finley, N,
Norlin A,
Baines DL,
and
Folkesson HG.
Alveolar epithelial fluid clearance is mediated by endogenous catecholamines at birth in guinea pigs.
J Clin Invest
101:
972-981,
1998
25.
Furriols, M,
Chillaron J,
Mora C,
Castello A,
Bertran J,
Camps M,
Testar X,
Vilaro S,
Zorzano A,
and
Palacin M.
rBAT, related to L-cystine transport, is localized to the microvilli of proximal straight tubules, and its expression is regulated in kidney by development.
J Biol Chem
268:
27060-27068,
1993
26.
Garty, H,
and
Palmer LG.
Epithelial sodium channels: function, structure, and regulation.
Physiol Rev
77:
359-396,
1997
27.
Gattone, VH, 2nd,
Maser RL,
Tian C,
Rosenberg JM,
and
Branden MG.
Developmental expression of urine concentration-associated genes and their altered expression in murine infantile-type polycystic kidney disease.
Dev Genet
24:
309-318,
1999[ISI][Medline].
28.
Geng, L,
Segal Y,
Pavlova A,
Barros EJ,
Lohning C,
Lu W,
Nigam SK,
Frischauf AM,
Reeders ST,
and
Zhou J.
Distribution and developmentally regulated expression of murine polycystin.
Am J Physiol Renal Physiol
272:
F451-F459,
1997
29.
Geng, L,
Segal Y,
Peissel B,
Deng N,
Pei Y,
Carone F,
Renke HG,
Glücksmann-Kuis AM,
Schneider MC,
Ericsson M,
Reeders ST,
and
Zhou J.
Identification and localization of polycystin, the PKD1 gene product.
J Clin Invest
98:
2674-2682,
1996
30.
Giebisch, G.
Renal potassium transport: mechanisms and regulation.
Am J Physiol Renal Physiol
274:
F817-F833,
1998
31.
Griffin, MD,
O'Sullivan DA,
Torres VE,
Grande JP,
Kanwar YS,
and
Kumar R.
Expression of polycystin in mouse metanephros and extrametanephric tissues.
Kidney Int
52:
1196-1205,
1997[ISI][Medline].
32.
Guillery, EN,
Huss DJ,
McDonough AA,
and
Klein LC.
Posttranscriptional upregulation of Na+-K+-ATPase in newborn guinea pig renal cortex.
Am J Physiol Renal Physiol
273:
F254-F263,
1997
33.
Guillery, EN,
Karniski LP,
Mathews MS,
Page WV,
Orlowski J,
Jose PA,
and
Robillard JE.
Role of glucocorticoids in the maturation of renal cortical Na+/H+ exchanger activity during fetal life in sheep.
Am J Physiol Renal Fluid Electrolyte Physiol
268:
F710-F717,
1995
34.
Harris, A,
Chalkley G,
Goodman S,
and
Coleman L.
Expression of the cystic fibrosis gene in human development.
Development
113:
305-310,
1991[Abstract].
35.
Hart, CD,
Flozak AS,
and
Simmons RA.
Modulation of glucose transport in fetal lung: a sexual dimorphism.
Am J Respir Cell Mol Biol
19:
63-70,
1998
36.
Hathout, EH,
Kumagai AK,
Sangkharat A,
Geffner ME,
and
Mullen Y.
Absence of GLUT2 protein in near-term fetal rat pancreatic islands.
Pancreas
14:
318-321,
1997[ISI][Medline].
37.
Hebert, SC.
General principles of the structure of ion channels.
Am J Med
104:
87-98,
1998[ISI][Medline].
38.
Hogan, BL.
Morphogenesis.
Cell
96:
225-233,
1999[ISI][Medline].
39.
Horster, M,
Huber S,
Tschop J,
Dittrich G,
and
Braun G.
Epithelial nephrogenesis.
Pflügers Arch
434:
647-660,
1997[ISI][Medline].
40.
Horster, MF,
Braun GS,
and
Huber SM.
Embryonic renal epithelia: induction, nephrogenesis and cell differentiation.
Physiol Rev
79:
1157-1191,
1999
41.
Huber, S,
Braun G,
Burger-Kentischer A,
Lukow B,
and
Horster M.
CFTR mRNA and its truncated splice variant (TRN-CFTR) are differentially expressed during collecting duct ontogeny.
FEBS Lett
423:
362-366,
1998[ISI][Medline].
42.
Huber, S,
Braun G,
Schroppel B,
and
Horster M.
Chloride channels. ClC-2 and ICln mRNA expression differs in renal epithelial ontogeny.
Kidney Int
54:
S-149-S-151,
1998.
43.
Huber, S,
Schroppel B,
Kretzler M,
Schlondorff D,
and
Horster M.
Single cell RT-PCR analysis of ClC-2 mRNA expression in ureteric bud tip.
Am J Physiol Renal Physiol
274:
F951-F957,
1998
44.
Huber, SM,
Braun GS,
and
Horster MF.
Expression of the epithelial sodium channel (ENaC) during ontogenic differentiation of the renal cortical collecting duct epithelium.
Pflügers Arch
437:
491-497,
1999[ISI][Medline].
45.
Huber, SM,
Braun GS,
Segerer S,
Veh RW,
and
Horster MF.
Metanephrogenic mesenchyme-to-epithelium transition induces profound expression changes of ion channels.
Am J Physiol Renal Physiol
279:
F65-F76,
2000
46.
Huber, SM,
and
Horster MF.
Ontogeny of apical membrane ion conductances and channel expression in cortical collecting duct cells.
Am J Physiol Renal Fluid Electrolyte Physiol
271:
F698-F708,
1996
47.
Huber, SM,
and
Horster MF.
Expression of a hypotonic swelling-activated Cl conductance during ontogeny of collecting duct epithelium.
Am J Physiol Renal Physiol
275:
F25-F32,
1998
48.
Hummler, E,
Barker P,
Gatzy J,
Beermann F,
Verdumo C,
Schmidt A,
Boucher R,
and
Rossier BC.
Early death due to defective neonatal lung liquid clearance in ENaC-deficient mice.
Nature Genet
12:
325-328,
1996[ISI][Medline].
49.
Hummler, E,
Barker P,
Talbot C,
Wang Q,
Verdumo C,
Grubb B,
Gatzy J,
Burnier M,
Horisberger JD,
Beermann F,
Boucher R,
and
Rossier BC.
A mouse model for the renal salt-wasting syndrome pseudohypoaldosteronism.
Proc Natl Acad Sci USA
94:
11710-11715,
1997
50.
Ibraghimow-Beskrovnaya, O,
Dackowski WR,
Foggensteiner L,
Coleman N,
Thiru S,
Petry LR,
Burn TC,
Connors TD,
van Raay T,
Bradley J,
Qian F,
Onuchic LF,
Watnik TJ,
Piontek K,
Hakim RM,
Landes GM,
Germino GG,
Sandford R,
and
Klinger KW.
Polycystin: in vitro synthesis, in vivo tissue expression, and subcellular localization identifies a large membrane-associated protein.
Proc Natl Acad Sci USA
94:
6397-6402,
1997
51.
Igarashi, P,
vanden Heuvel GB,
Payne JA,
and
Forbush B, III.
Cloning, embryonic expression, and alternative splicing of a murine kidney-specific Na-K-Cl cotransporter.
Am J Physiol Renal Fluid Electrolyte Physiol
269:
F405-F418,
1995
52.
Ingbar, DH,
Duvick S,
Savick SK,
Schellhase DE,
Detterding R,
Jamieson JD,
and
Shannon JM.
Developmental changes of fetal rat lung Na-K-ATPase after maternal treatment with dexamethasone.
Am J Physiol Lung Cell Mol Physiol
272:
L665-L672,
1997
53.
King, LS,
Nielsen S,
and
Agre P.
Aquaporin-1 water channel protein in lung. Ontogeny, steroid-induced expression, and distribution in rat.
J Clin Invest
97:
2183-2191,
1996
54.
King, LS,
Nielsen S,
and
Agre P.
Aquaporins in complex tissues. I. Developmental patterns in respiratory and glandular tissues of rat.
Am J Physiol Cell Physiol
273:
C1541-C1548,
1997[ISI][Medline].
55.
Lopez-Nieto, CE,
You G,
Bush KT,
Barros EJG,
Beier DR,
and
Nigam SK.
Molecular cloning and characterization of NKT, a gene product related to the organic cation transporter family that is almost exclusively expressed in the kidney.
J Biol Chem
272:
6471-6478,
1997
56.
Mahraoui, L,
Rousset M,
Dussaulx E,
Darmoul D,
Zweibaum A,
and
Brot-Laroche E.
Expression and localization of GLUT-5 in Caco-2 cells, human small intestine, and colon.
Am J Physiol Gastrointest Liver Physiol
263:
G312-G318,
1992
57.
Matsumoto, K,
Takao Y,
Akazawa S,
Yano M,
Uotani S,
Kawasaki E,
Takino H,
Yamasaki H,
Okuno S,
Yamaguchi Y,
and
Nagataki S.
Developmental change of facilitative glucose transporter expression in rat embryonal and fetal intestine.
Biochem Biophys Res Commun
193:
1275-1282,
1993[ISI][Medline].
58.
Matsumoto, T,
Winkler CA,
Brion LP,
and
Schwartz GJ.
Expression of acid-base-related proteins in mesonephric kidney of the rabbit.
Am J Physiol Renal Fluid Electrolyte Physiol
267:
F987-F997,
1994
59.
McCray, PB, Jr,
Reenstra WW,
Louie E,
Johnson J,
Bettencourt JD,
and
Bastacky J.
Expression of CFTR and presence of cAMP-mediated fluid secretion in human fetal lung.
Am J Physiol Lung Cell Mol Physiol
262:
L472-L481,
1992
60.
McCray, PB, Jr,
Wohlford-Lenane CL,
and
Snyder JM.
Localization of cystic fibrosis transmembrane conductance regulator mRNA in human fetal lung tissue by in situ hybridization.
J Clin Invest
90:
619-625,
1992[ISI][Medline].
61.
McDonald, FJ,
Snyder PM,
McCray PB, Jr,
and
Welsh MJ.
Cloning, expression, and tissue distribution of a human amiloride-sensitive Na+ channel.
Am J Physiol Lung Cell Mol Physiol
266:
L728-L734,
1994
62.
McDonald, FJ,
Yang B,
Hrstka RF,
Drummond HA,
Tarr DE,
McCray PB, Jr,
Stokes JB,
Welsh MJ,
and
Williamson RA.
Disruption of the subunit of the epithelial Na+ channel in mice: Hyperkalemia and neonatal death associated with a pseudohypoaldosteronism phenotype.
Proc Natl Acad Sci USA
96:
1727-1731,
1999
63.
McGrath, SA,
Basu A,
and
Zeitlin PL.
Cystic fibrosis gene and protein expression during fetal lung development.
Am J Respir Cell Mol Biol
8:
201-208,
1993[ISI][Medline].
64.
Morley, GP,
Callaghan JM,
Rose JB,
Toh BH,
Gleeson PA,
and
van Driel IR.
The mouse gastric H,K-ATPase subunit. Gene structure and co-ordinate expression with the subunit during ontogeny.
J Biol Chem
267:
1165-1174,
1992
65.
Murray, CB,
Chu S,
and
Zeitlin PL.
Gestational and tissue-specific regulation of ClC-2 chloride channel expression.
Am J Physiol Lung Cell Mol Physiol
271:
L829-L837,
1996
66.
O'Brodovich, H,
Staub O,
Rossier BC,
Geering K,
and
Kraehenbuhl JP.
Ontogeny of 1- and
1-isoforms of Na+-K+-ATPase in fetal distal rat lung epithelium.
Am J Physiol Cell Physiol
264:
C1137-C1143,
1993
67.
O'Brodovich, H,
Canessa C,
Ueda J,
Rafii B,
Rossier BC,
and
Edelson J.
Expression of the epithelial Na+ channel in the developing rat lung.
Am J Physiol Cell Physiol
265:
C491-C496,
1993
68.
Ostrowski, NL,
Young WS, III.,
Knepper MA,
and
Lolait SL.
Expression of vasopressin V1a and V2 receptor messenger ribonucleic acid in the liver and kidney of embryonic, developing, and adult rats.
Endocrinology
133:
1849-1859,
1993[Abstract].
69.
Pang, K,
Mukonoweshuro C,
and
Wong GG.
Beta cells arise from glucose transporter type 2 (Glut2)-expressing epithelial cells of developing rat pancreas.
Proc Natl Acad Sci USA
91:
9559-9563,
1994
70.
Petershack, JA,
Nagaraja SC,
and
Guillery EN.
Role of glucocorticoids in the maturation of renal cortical Na+-K+-ATPase during fetal life in sheep.
Am J Physiol Regulatory Integrative Comp Physiol
276:
R1825-R1832,
1999
71.
Pitkänen, O,
Tanswell AK,
Downey G,
and
O'Brodovich H.
Increased PO2 alters the bioelectric properties of fetal distal lung epithelium.
Am J Physiol Lung Cell Mol Physiol
270:
L1060-L1066,
1996
72.
Pradervand, S,
Barker PM, Q,
Wang Ernst SA,
Beermann F,
Grubb BR,
Burnier M,
Schmidt A,
Bindels RJM,
Gatzy JT,
Rossier BC,
and
Hummler E.
Salt restriction induces pseudohypoaldosteronism type 1 in mice expressing low levels of the -subunit of the amiloride-sensitive epithelial sodium channel.
Proc Natl Acad Sci USA
96:
1732-1737,
1999
73.
Puchal, AA,
and
Buddington RK.
Postnatal development of monosaccharide transport in pig intestine.
Am J Physiol Gastrointest Liver Physiol
262:
G895-G902,
1992
74.
Rafii, B,
Tanswell AK,
Otulakowski G,
Pitkänen O,
Belcastro-Taylor R,
and
O'Brodovich H.
O2-induced ENaC expression is associated with NF-B activation and blocked by superoxide scavenger.
Am J Physiol Lung Cell Mol Physiol
275:
L764-L770,
1998
75.
Ruddy, MK,
Drazen JM,
Pitkänen OM,
Rafii B,
O'Brodovich HM,
and
Harris HW.
Modulation of aquaporin 4 and the amiloride-inhibitable sodium channel in perinatal rat lung epithelial cells.
Am J Physiol Lung Cell Mol Physiol
274:
L1066-L1072,
1998
76.
Sabolic, I,
Katsura T,
Verbavatz JM,
and
Brown D.
The AQP2 water channel: effect of vasopressin treatment, microtubule disruption, and distribution in neonatal rats.
J Membr Biol
143:
165-175,
1995[ISI][Medline].
77.
Satlin, LM,
and
Palmer LG.
Apical K+ conductance in maturing rabbit principal cells.
Am J Physiol Renal Physiol
272:
F397-F404,
1997
78.
Schmitt, R,
Ellison DH,
Farman N,
Rossier BC,
Reilly RF,
Reeves WB,
Oberbaumer I,
Tapp R,
and
Bachmann S.
Developmental expression of sodium entry pathways in rat nephron.
Am J Physiol Renal Physiol
276:
F367-F381,
1999
79.
Schwiebert, EM,
Benos DJ,
Egan ME,
Stutts MJ,
and
Guggino WB.
CFTR is a conductance regulator as well as a chloride channel.
Physiol Rev
79:
S145-S166,
1999[Medline].
80.
Sha, M,
Quigley R,
and
Baum M.
Maturation of rabbit proximal straight tubule chloride/base exchange.
Am J Physiol Renal Physiol
274:
F883-F888,
1998
81.
Shneider, BL,
Setchell KDR,
and
Crossman MW.
Fetal and neonatal expression of the apical sodium-dependent bile acid transporter in the rat ileum and kidney.
Pediatr Res
42:
189-194,
1997[Abstract].
82.
Shu, R,
David ES,
and
Ferraris RP.
Luminal fructose modulates fructose transport and GLUT-5 expression in small intestine of weaning rats.
Am J Physiol Gastrointest Liver Physiol
274:
G232-G239,
1998
83.
Siga, E,
and
Horster MF.
Regulation of osmotic water permeability during differentiation of inner medullary collecting duct.
Am J Physiol Renal Fluid Electrolyte Physiol
260:
F710-F716,
1991
84.
Simmons, RA,
Flozak AS,
and
Ogata ES.
Glucose regulates Glut 1 function and expression in fetal rat lung and muscle in vitro.
Endocrinology
132:
2312-2318,
1993[Abstract].
85.
Simon, DB,
Karet FE,
Hamdan JM,
Di Pietro A,
Sanjad SA,
and
Lifton RP.
Bartter's syndrome, hypokaliaemic alkalosis with hypercalciuria, is caused by mutations in the Na-K-2Cl cotransporter NKCC2.
Nature Genet
13:
183-188,
1996[ISI][Medline].
86.
Sweezey, NB,
Ghibu F,
and
Gagnon S.
Sex hormones regulate CFTR in developing fetal rat lung epithelial cells.
Am J Physiol Lung Cell Mol Physiol
272:
L844-L851,
1997
87.
Talbot, CL,
Bosworth DG,
Briley EL,
Fenstermacher DA,
Boucher RC,
Gabriel SE,
and
Barker PM.
Quantitation and localization of ENaC subunit expression in fetal, newborn, and adult mouse lung.
Am J Respir Cell Mol Biol
20:
398-406,
1999
88.
Tchepichev, S,
Ueda J,
Canessa C,
Rossier BC,
and
O'Brodovich H.
Lung epithelial Na channel subunits are differentially regulated during development and by steroids.
Am J Physiol Cell Physiol
269:
C805-C812,
1995[Abstract].
89.
Tessier, GJ,
Lester GD,
Langham MR,
and
Cassin S.
Ion transport properties of fetal sheep alveolar epithelial cells in monolayer culture.
Am J Physiol Lung Cell Mol Physiol
270:
L1008-L1016,
1996
90.
Tizzano, EF,
Chitayat D,
and
Buchwald M.
Cell-specific localization of CFTR mRNA shows developmentally regulated expression in human fetal tissues.
Hum Mol Genet
2:
219-224,
1993[Abstract].
91.
Tizzano, EF,
O'Brodovich H,
Chitayat D,
Benichou JC,
and
Buchwald M.
Regional expression of CFTR in developing human respiratory tissues.
Am J Respir Cell Mol Biol
10:
355-362,
1994[Abstract].
92.
Toloza, EM,
and
Diamond J.
Ontogenetic development of nutrient transporters in rat intestine.
Am J Physiol Gastrointest Liver Physiol
263:
G593-G604,
1992
93.
Traebert, M,
Lötscher M,
Aschwanden R,
Ritthaler T,
Biber J,
Murer H,
and
Kaissling B.
Distribution of the sodium-phosphate transporter (NaPi-2) during the postnatal ontogeny of the rat kidney.
J Am Soc Nephrol
10:
1407-1415,
1999
94.
Umenishi, F,
Carter EP,
Yang B,
Oliver B,
Matthay MA,
and
Verkman AS.
Sharp increase in rat lung water channel expression in the perinatal period.
Am J Respir Cell Mol Biol
15:
673-679,
1996[Abstract].
95.
Van Adelsberg, J.
Peptides from the PKD repeats of polycystin, the PKD1 gene product, modulate pattern formation in the developing kidney.
Dev Genet
24:
299-308,
1999[ISI][Medline].
96.
Vargas-Pussou, R,
Feldmann D,
Vollmer M,
Konrad M,
Kelly L,
van den Heuvel LP,
Tebourbi L,
Brandis M,
Karolyi L,
Hebert SC,
Lemmink HH,
Deschenes G,
Hildebrandt F,
Seyberth HW,
Guay-Woodford LM,
Knoers NV,
and
Antignac C.
Novel molecular variants of the Na-K-2Cl cotransporter gene are responsible for antenatal Bartter syndrome.
Am J Hum Genet
62:
1332-1340,
1998[ISI][Medline].
97.
Vehaskari, VM,
Hempe JM,
Manning J,
Aviles DH,
and
Carmichael MC.
Developmental regulation of ENaC subunit mRNA levels in rat kidney.
Am J Physiol Cell Physiol
274:
C1661-C1666,
1998
98.
Venkatesh, VC,
and
Katzberg HD.
Glucocorticoid regulation of epithelial sodium channel genes in human fetal lung.
Am J Physiol Lung Cell Mol Physiol
273:
L227-L233,
1997
99.
Voilley, N,
Lingueglia E,
Champigny G,
Mattei MG,
Waldmann R,
Lazdunski M,
and
Barbry P.
The lung amiloride-sensitive Na+ channel: biophysical properties, pharmacology, ontogenesis, and molecular cloning.
Proc Natl Acad Sci USA
91:
247-251,
1994[Abstract].
100.
Watanabe, S,
Matsushita K,
McCray PB, Jr,
and
Stokes JB.
Developmental expression of the epithelial Na+ channel in kidney and uroepithelia.
Am J Physiol Renal Physiol
276:
F304-F324,
1999
101.
Watanabe, S,
Matsushita K,
Stokes JB,
and
McCray PB, Jr.
Developmental regulation of epithelial sodium channel subunit mRNA expression in rat colon and lung.
Am J Physiol Gastrointest Liver Physiol
275:
G1227-G1235,
1998
102.
Wickman, K,
Seldin MF,
James MR,
Gendler SJ,
and
Clapham DE.
Partial structure, chromosome localization, and expression of the mouse ICln gene.
Genomics
40:
402-408,
1997[ISI][Medline].
103.
Wijkhuisen, A,
Djouadi F,
Vilar J,
Merlet-Benichou C,
and
Bastin J.
Birth-related changes in energy metabolism enzymes and Na-K-ATPase in kidney proximal convoluted tubule cells.
Am J Physiol Cell Physiol
272:
C787-C793,
1997
104.
Wintour, EM,
Earnest L,
Alcorn D,
Butkus A,
Shandley L,
and
Jeyaseelan K.
Ovine AQP1: cDNA cloning, ontogeny, and control of renal gene expression.
Pediatr Nephrol
12:
545-553,
1998[ISI][Medline].
105.
Yamamoto, T,
Sasaki S,
Fushimi K,
Ishibashi K,
Yaoita E,
Kawasaki K,
Fujinaka H,
Marumo F,
and
Kihara I.
Expression of AQP family in rat kidneys during development and maturation.
Am J Physiol Renal Physiol
272:
F198-F204,
1997
106.
Yasui, M,
Marples D,
Belusa R,
Eklof AC,
Celsi G,
Nielsen S,
and
Aperia A.
Development of urinary concentrating capacity: role of aquaporin-2.
Am J Physiol Renal Fluid Electrolyte Physiol
271:
F461-F468,
1996
107.
Yasui, M,
Serlachius E,
Lofgren M,
Belusa R,
Nielsen S,
and
Aperia A.
Perinatal changes in expression of aquaporin-4 and other water and ion transporters in rat lung.
J Physiol (Lond)
505:
3-11,
1997[Abstract].
108.
You, G,
Lee WS,
Barros EJ,
Kanai Y,
Huo TL,
Khawaja S,
Wells RG,
Nigam SK,
and
Hediger MA.
Molecular characteristics of Na+-coupled glucose transporters in adult and embryonic rat kidney.
J Biol Chem
270:
29365-29371,
1995
109.
Zelikovic, I,
Stejskal E,
Lohstroh P,
Budreau A,
and
Chesney RW.
Developmental maturation of Na+-H+ exchange in rat renal tubular brush-border membrane.
Am J Physiol Renal Fluid Electrolyte Physiol
261:
F1017-F1025,
1991
110.
Zhou, L,
Graeff RW,
McCray PB, Jr,
Simonet WS,
and
Whitsett JA.
Keratinocyte growth factor stimulates CFTR-independent fluid secretion in the fetal lung in vitro.
Am J Physiol Lung Cell Mol Physiol
271:
L987-L994,
1996
111.
Zolotnitskaya, A,
and
Satlin LM.
Developmental expression of ROMK in rat kidney.
Am J Physiol Renal Physiol
276:
F825-F836,
1999